NDAINTRAVENOUSPOWDER
Approved
Jun 2022
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Pemetrexed ditromethamine is an intravenous powder formulation of pemetrexed, a multi-targeted antifolate chemotherapy agent. It is used to treat certain cancers, including mesothelioma and non-small cell lung cancer, by inhibiting folate-dependent enzymes critical to DNA synthesis. The ditromethamine salt formulation represents a reformulation of the established pemetrexed therapeutic.
Peak
At peak lifecycle stage with moderate competitive pressure (30%), the product likely supports a stable commercial team focused on market maintenance and share defense.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on pemetrexed ditromethamine offers career stability in oncology at a mature product lifecycle stage with established commercial infrastructure. Limited job openings (0 linked positions) suggest specialized or backfill hiring rather than team expansion, making this role suitable for specialists seeking deep oncology expertise rather than rapid career growth.
Brand Manager
Worked on PEMETREXED DITROMETHAMINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.